19
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      In vitro Antimicrobial Activity of Traditional Plant Used in Mestizo Shamanism from the Peruvian Amazon in Case of Infectious Diseases

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Context:

          Our survey was performed near Iquitos (Peruvian Amazon) and its surroundings and leads us to consider Mestizo ethnomedical practices. The plant species reported here are traditionally used for ailments related to microbial infections. Inhabitants of various ethnic origins were interviewed, and 52 selected plants extracts were evaluated for their antimicrobial properties against a panel of 36 sensitive and multi-resistant bacteria or yeast. The study aimed at providing information on antimicrobial plant extract activities and the ethnomedical context of Mestizo riverine populations from Loreto (Peru).

          Material and Method:

          The minimum inhibitory concentrations (MICs) of the plant crude extracts were carried out using the agar dilution method and ranged between 0.075 and 5.0 mg/ml.

          Results:

          Of the 40 plants analyzed, 9 species showed MIC ≤0.3 mg/ml ( Anacardium occidentale, Couroupita guianensis, Croton lechleri, Davilla rugosa, Erythrina amazonica, Jacaranda copaia subsp. Spectabilis, Oenocarpus bataua, Peperomia macrostachya, and Phyllanthus urinaria) for one or several of the 36 microorganisms and only 6 drug extracts were inactive. Among the 40 plants, 13 were evaluated for the first time for an antibacterial activity.

          Conclusion:

          This evaluation of the antimicrobial activity of 40 plants using an approved standard methodology allowed comparing those activities against various microbes to establish antimicrobial spectra of standardized plant extracts, and give support to the traditional use of these plants. It may also help discovering new chemical classes of antimicrobial agents that could serve against multi-resistant bacteria.

          SUMMARY

          • This study leads us to consider Mestizo ethnomedical practices near Iquitos (Peruvian Amazon) and its surroundings. The plant species reported here are traditionally used for ailments related to microbial infections. 52 selected plants extracts were evaluated for their antimicrobial properties against a panel of 36 sensitive and multi resistant bacteria or yeast. The study aimed at providing information on antimicrobial plant extract activities and the ethnomedical context of Mestizo riverine populations from Loreto.

          Related collections

          Most cited references34

          • Record: found
          • Abstract: found
          • Article: not found

          New insights into meticillin-resistant Staphylococcus aureus (MRSA) pathogenesis, treatment and resistance.

          Meticillin-resistant Staphylococcus aureus (MRSA) remains one of the principal multiply resistant bacterial pathogens causing serious healthcare-associated and community-onset infections. This paper reviews recent studies that have elucidated the virulence strategies employed by MRSA, key clinical trials of agents used to treat serious MRSA infections, and accumulating data regarding the implications of antibacterial resistance in MRSA for clinical success during therapy. Recent pre-clinical data support a species-specific role for Panton-Valentine leukocidin in the development of acute severe S. aureus infections and have elucidated other virulence mechanisms, including novel modes of internalisation, varying post-invasion strategies (featuring both upregulation and downregulation of virulence factors) and phenotypic switching. Recent double-blind, randomised, phase III/IV clinical trials have demonstrated the efficacy of linezolid and telavancin in hospital-acquired pneumonia (HAP) and complicated skin and skin-structure infections (cSSSIs) caused by MRSA. Tigecycline was non-inferior to imipenem/cilastatin in non-ventilator-associated HAP but was inferior in ventilator-associated pneumonia and has shown a higher rate of death than comparators on meta-analysis. Ceftaroline was clinically and microbiologically non-inferior to vancomycin/aztreonam in the treatment of MRSA cSSSI. Key resistance issues include a rise in vancomycin minimum inhibitory concentrations in MRSA, reports of clonal isolates with linezolid resistance mediated by acquisition of the chloramphenicol/florfenicol resistance gene, and case reports of daptomycin resistance resulting in clinical failure. Novel antimicrobial targets must be identified with some regularity or we will face the risk of untreatable S. aureus infections. Copyright © 2011 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Antibiotic resistance in Neisseria gonorrhoeae: origin, evolution, and lessons learned for the future.

            The strict human pathogen Neisseria gonorrhoeae has caused gonorrhea for thousands of years, and currently gonorrhea is the second most prevalent bacterial sexually transmitted infection worldwide. Given the ancient nature of N. gonorrhoeae and its unique obligate relationship with humankind over the millennia, its remarkable ability to adapt to the host immune system and cause repeated infections, and its propensity to develop resistance to all clinically useful antibiotics, the gonococcus is an ideal pathogen on which to study the evolution of bacterial pathogenesis, including antimicrobial resistance, over the long term and within the host during infection. Recently, the first gonococcus displaying high-level resistance to ceftriaxone, identified in Japan, was characterized in detail. Ceftriaxone is the last remaining option for empirical first-line treatment, and N. gonorrhoeae now seems to be evolving into a true "superbug." In the near future, gonorrhea may become untreatable in certain circumstances. Herein, the history of antibiotics used for treatment of gonorrhea, the evolution of resistance emergence in N. gonorrhoeae, the linkage between resistance and biological fitness of N. gonorrhoeae, lessons learned, and future perspectives are reviewed and discussed. © 2011 New York Academy of Sciences.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Making Kin Out Of Others In Amazonia

                Bookmark

                Author and article information

                Journal
                Pharmacogn Mag
                Pharmacogn Mag
                PM
                Pharmacognosy Magazine
                Medknow Publications & Media Pvt Ltd (India )
                0973-1296
                0976-4062
                October 2015
                : 11
                : Suppl 4
                : S625-S633
                Affiliations
                [1]Division of Natural Products Chemistry, Laboratoire Régional de Recherche en Agro-alimentaire et Biotechnologie: Institut Charles Viollette, Lille, France
                [1 ]Division of Anthropology, Ecole pratique des hautes études, Laboratoire d’anthropologie sociale, 75005 Paris, Sorbonne, France
                [2 ]Division of Natural Products Chemistry, Laboratorio de Investigación de Productos Naturales Antiparasitarios de la Amazonia, Universidad Nacional de la Amazonía Peruana, AA.HH., Nuevo San Lorenzo, Iquitos, Perú
                [3 ]Division of Bacteriology, Laboratoire de Bactériologie, Faculté des Sciences Pharmaceutiques et Biologiques, Université Lille Nord de France (Lille 2), F-59006 Lille Cedex, France
                Author notes
                Correspondence: Dr. Vincent Roumy, Division of Natural Products Chemistry, Laboratoire Régional de Recherche en Agro-alimentaire et Biotechnologie: Institut Charles Viollette, Lille, France. E-mail: vincent.roumy@ 123456univ-lille.fr
                Article
                PM-11-625
                10.4103/0973-1296.172975
                4787099
                27013805
                82982bfb-1929-4f61-933c-f9a146d896b4
                Copyright: © 2015 Pharmacognosy Magazine

                This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.

                History
                Categories
                Original Article

                Pharmacology & Pharmaceutical medicine
                antimicrobial activity,iquitos,loreto,medicinal plant,traditional use

                Comments

                Comment on this article